A unique culture delivering exceptional solutions
Every project. Every partnership. Every solution.
A unique culture delivering exceptional solutions
Every project. Every partnership. Every solution.
A unique culture delivering exceptional solutions
50 years ago, our late founder and Chairman, Sir Allen McClay, pursued his vision of one company making a substantial contribution to healthcare across the globe and began the journey of Almac. Today, Allen’s vision and legacy continues to live on through our valued employees. Our unique culture, passionate people and constant drive for innovative solutions is at the heart of what we do and makes Almac a very special organisation.
We are proud of our global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
Almac people continue to deliver this unique culture of unrivalled commitment to the long-term relationships we develop and nurture.
A culture of understanding.
A culture of exceptional solutions.
And as Almac now looks forward to continuing success alongside partners across the world, our guarantee to our employees, and our customers, is this…
We will be exceptional. Always.
Click here to learn more about our extensive range of integrated services across the drug product lifecycle.
50 Years of Successful Growth
2019
Construction of Almac Group’s EU Campus in Dundalk, Ireland is complete
2019
Almac Group opens MED-Lab exhibition in W5, Belfast, Northern Ireland
2019
Almac Group announces additional expansion of its Global Analytical Services Capability, investing significantly in additional laboratory space at its facility in Athlone, Ireland
2018
Almac Group celebrate 50 years
2018
Almac Group turnover surpasses £500 million for first time
2018
Almac Group expands with opening of £20 million Cold Chain Facility at its Global HQ in Craigavon, UK
2017
Almac Group acquires BioClin Laboratories, Athlone, Ireland
2017
Almac Group establishes European Campus in Dundalk, Ireland
2016
Almac Group opens its new companion diagnostic development facility located in the Research Triangle region of North Carolina, USA
2015
Almac Group confirms a £16 million investment to expand its Formulation and Analytical Development services to meet ongoing client demand in Loughborough, England
2015
Almac Group acquires Arran Chemical Company, Athlone, Ireland
2014
Almac Group opens its new Asia Pacific Headquarter facility in Singapore
2013
Almac Group opens its dedicated facility for Non-GMP formulation development
2013
Almac Group opens its Commercial Packaging facility in Audubon, PA, USA
2011
Almac Group opens its new North American Headquarter facility in Souderton, PA, USA
2010
On 12 January, just months before the NAHQ is completed, Sir Allen McClay passes away – However, his vision lives on through his work and the commitment of the Almac Group
2008
Almac Discovery, an independent company focused exclusively on the discovery and development of novel and innovative approaches to the treatment of cancer is established
2008
Almac Group invests $120M in its new North American Headquarters (NAHQ)
2006
Allen McClay OBE, CBE becomes Sir Allen McClay when Prince Charles knights him at Buckingham Palace
2005
Almac Group opens dedicated facilities for GMP formulation development and biomarker discovery & development services
2004
Almac Group acquires Peptide & Protein research facility in Elvingston, Scotland
2004
Allen McClay OBE, CBE announces the purchase of Galen Ltd, the UK based Ethical Pharmaceutical Products Sales and Marketing business
2003
Almac Group announces the acquisition of Pharmaceutical Manufacturing operations from Galen Holdings Plc
2003
Almac Group acquires its Biomarker Discovery & Development business
2003
Almac Group opens its Global Headquarters in Craigavon, UK
2002
Almac Group founded by Allen McClay OBE, CBE created from Galen Services businesses
2001
Allen McClay OBE, CBE announces his retirement from Galen Holdings
2000
Clinical Trial Supply business acquired from Duke University in Durham, NC, USA
2000
Galen acquires Warner Chilcott – restructure of organisation to Galen Pharma and Galen Services
1999
Purchase of ICTI later to become Almac Clinical Technologies
1997
Galen Ltd floated on the stock market to become Galen Holdings Plc – Northern Ireland’s first £ billion company
1996
API Manufacturing and Chemical Development services established in Craigavon, UK
1996
Expansion to the US with Clinical Trial Supply operations commences in Audubon, PA, USA
1988
Clinical Trial Supply operations commence in Craigavon, UK
1978
Pharmaceutical Manufacturing commences in Craigavon, UK
1968
Galen Ltd founded by Allen McClay